title: Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice.
abstract: In culture, exposure to penicillin and other stressors induce chlamydiae to enter a non-infectious but viable state termed persistence. Chlamydiae may reenter their normal developmental cycle after stressor removal. Though aberrant RB similar to those present in culture models of persistence have been observed within infected tissues, the existence of persistent chlamydiae has not been definitively demonstrated in vivo. As a result, the role of persistent organisms in pathogenesis is undefined. In order to establish an experimentally tractable model of in vivo persistence, Chlamydia muridarum vaginally-infected mice were gavaged with either water or amoxicillin (amox). Vaginal swabs were collected for chlamydial titration and RNA isolated for quantification of pre-16s rRNA. Uterine tissue was analyzed by transmission electron microscopy (TEM). Although amox-treatment reduced vaginal shedding by >99%, C. muridarum pre-16s rRNA accumulation was unchanged by treatment. These data indicate that the amox-exposed organisms were viable but not infectious. Furthermore, TEM analyses demonstrated that inclusions in amox-treated animals contained primarily large, aberrant RB, but those observed in untreated control animals were normal. Collectively, these data suggest that amoxicillin treatment induces C. muridarum to enter the persistent state in vivo. This model also represents the first experimentally tractable animal model of chlamydial persistence.
authors.affiliation: Department of Biomedical Sciences, East Tennessee State University, Quillen College of Medicine, Johnson City, TN 37614, USA.
authors.forename: R
authors.initials: R
authors.lastname: Phillips Campbell
authors.forename: J
authors.initials: J
authors.lastname: Kintner
authors.forename: J
authors.initials: J
authors.lastname: Whittimore
authors.forename: R V
authors.initials: RV
authors.lastname: Schoborg
mesh_terms: D000658:Amoxicillin / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D057138:Bacterial Shedding; D002460:Cell Line; D002690:Chlamydia Infections / Q000188:drug therapy / Q000382:microbiology*; D023502:Chlamydia muridarum / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000648:ultrastructure; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D050296:Microbial Viability; D046529:Microscopy, Electron, Transmission; D012329:RNA, Bacterial / Q000302:isolation & purification; D014599:Uterus / Q000382:microbiology / Q000648:ultrastructure; D014621:Vagina / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D012329:RNA, Bacterial; D000658:Amoxicillin